Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Temporary Funding For US Agencies Delays $5M For FDA’s Cannabidiols Regulatory Pathway Work

Sep 29 2020

• By Malcolm Spicer

Related Content

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development

Jul 10 2020

‘FASTER’ Path For US FDA To Identify Allergens, Impose Related Rules Passes House Committee

Jul 16 2020

Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking

Aug 04 2020

Additional Topics

United States Cannabidiol CBD Legislation FDA Advertising, Marketing & Sales Commercial Cosmetics Dietary Supplements Manufacturing OTC Drugs Policy Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window